Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bio Vitos Pharma AB
AB
Active
Org 5568115272
Nanna Svartz Väg 4, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2010 · 16 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Bio Vitos Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
3M
0M
2020
1M
2021
1M
2022
3M
2023
0M
2024
EBITDA
SEK millions
0M
-3M
-5M
-8M
-10M
-6M
2020
-8M
-33%
2021
-8M
0%
2022
-3M
+63%
2023
-3M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
307
1 121
1 320
3 181
111
Staff expenses
—
—
—
—
—
EBITDA
−6 024
−7 534
−7 775
−2 713
−3 318
Depreciation & amort.
−5 676
−6 453
−7 155
−5 280
−14 863
EBIT
−11 700
−13 987
−14 930
−7 993
−18 181
Net financials
2
33
30
−15 795
−1 888
Profit before tax
−11 698
−13 954
−14 900
−23 788
−20 069
Tax
−0
−0
−0
−0
−0
Net profit
−11 698
−13 954
−14 900
−23 788
−20 069
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
35 782
35 497
26 450
22 997
16 316
Equity
33 524
33 535
24 923
21 990
15 921
Long-term debt
0
0
0
0
0
Short-term debt
2 258
1 962
1 527
1 007
395
Total debt
2 258
1 962
1 527
1 007
395
Financial ratios
5-year trend
EBITDA margin
-2989.2%
This company
15.8%
Market median
-19019% vs market
2020
2024
Equity ratio
97.6%
This company
38.2%
Market median
+155% vs market
2020
2024
Return on equity
-126.1%
This company
18.4%
Market median
-785% vs market
2020
2024
Net profit margin
-18080.2%
This company
8.1%
Market median
-223312% vs market
2020
2024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
2020
2024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Bio Vitos Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
